AndroGel: Benefits, Daily Dose and Gel-versus-Shot Trade-offs
Testosterone without injections
AndroGel can improve symptoms of diagnosed testosterone deficiency without needles. Its main trade-offs are a daily skin routine, variable absorption and avoiding transfer to a partner or child.
Gel and injections deliver the same hormone differently. Equal package milligrams do not give equal exposure.
Daily skin application
Applied amount ≠ absorbed amount
A pump count belongs to a specific product strength.
Protect people around you
- Clean hands Wash after application.
- Dry + cover Cover the dry site with clothing.
- Before skin contact Wash the application site.
Dose, frequency and duration
40.5 mg
Starting applied amount
AndroGel 1.62%: two pump actuations or one 40.5 mg packet. This is the amount applied to skin.
Daily
Morning routine
The 1.62% label specifies shoulders and upper arms. Prescriber adjustments use correctly timed tests.
Ongoing
Replacement, with review
Treatment continues when appropriate; there is no fixed bodybuilding cycle.
Product label. Applied mg is not absorbed mg, and these pump instructions do not apply to 1% gel or other brands.
A gel changes delivery, not the hormone
| Compare | Potential practical advantage | What still needs attention |
|---|---|---|
| No injection | Testosterone is applied to the skin | Absorption and daily routine affect exposure |
| Daily application | No repeated oil injections | Missed doses and application changes matter |
| Treating deficiency | Symptoms may improve when the diagnosis is correct | A higher number does not guarantee every symptom improves |
| Skin application | Convenient for some households | Transfer precautions protect other people |
What improvements can you expect?
In the Testosterone Trials, symptomatic men aged 65 and older with low testosterone received gel or placebo for a year. Testosterone improved sexual-function measures and some mood measures, but did not meet the primary vitality or walking-distance outcomes in the relevant trials. This supports specific benefits, not an all-purpose energy or anti-aging claim. Snyder et al., 2016
Diagnosis still matters. The Endocrine Society recommends symptoms plus consistently low, accurately measured testosterone, with evaluation of the cause. A single low result or fatigue alone does not settle that question. Current Society statement
Check the strength before counting pumps
AndroGel 1% and 1.62% are different products. Pump output, sites of application and instructions are not automatically interchangeable. The amount applied to skin is also not the amount reaching the blood; do not convert a gel’s milligrams directly into an injectable dose.
For AndroGel 1.62%, follow its specific application and blood-test instructions. Its label uses a pre-dose morning testosterone measurement for titration. A general online instruction about drawing blood after gel application may describe a different product or monitoring approach. AndroGel 1.62% label
Make transfer prevention part of the routine
The product label calls for washing hands after application, allowing the site to dry, covering it with clothing and washing the application site before anticipated direct skin contact. Follow the label’s bathing restrictions as well. These steps are part of using the medicine, not optional housekeeping.
AndroGel 1.62% is not indicated for women. Unintended exposure can cause androgen effects such as new body hair or voice changes; children may develop early signs of sexual development. These changes require medical assessment.
Children and others should not contact unwashed, uncovered application sites. Accidental exposure needs prompt washing and clinical advice if symptoms or significant exposure occur.
What should follow-up check besides testosterone?
TRAVERSE studied monitored 1.62% testosterone gel in men with hypogonadism and elevated cardiovascular risk. It met its noninferiority criterion for major cardiovascular events, while some other adverse events were more frequent with testosterone. It does not validate high-dose steroid use or every testosterone formulation. TRAVERSE primary report
A gel can change DHT as well as testosterone, but that does not establish a universal ranking of scalp or prostate harm against injections. The current gel label also includes blood-pressure monitoring. Follow-up should assess benefits and adverse effects rather than focus solely on reaching a target testosterone number.
Common questions
Will it preserve fertility? External testosterone can suppress sperm production. Discuss fertility before treatment; gel does not avoid this simply because it is topical.
Is gel weaker than an injection? The delivered exposure and response matter, not the route alone. Equal package milligrams are not comparable doses.
Can I use a plotter instead of a blood test? No. Skin absorption varies, and a model does not measure your response. See reading bloodwork.
Sources and review notes
Checked October 12, 2026. The AndroGel 1.62% label supports the product-specific applied amount, transfer precautions and monitoring. The Testosterone Trials studied symptomatic men aged 65 and older; their findings are not a promise of the same response in every user. TRAVERSE concerns monitored replacement in its enrolled population, not performance-enhancing exposure. Links to the original studies and label appear beside the relevant sections.
Related compounds & model context
Article citations are linked in the text. Related catalog entries have separate model inputs and source notes, which may include unverified estimates. See our methodology for model assumptions and limitations.